Ajax-Loading

Sino Biopharmaceutical Ltd - Ebitda Per Share

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD.

The item "Ebitda-Per-Share" stands at 0.333 Hong Kong Dollars as of 06/30/2025, the highest value since 09/30/2023.

As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Ebitda Per Share" stands at 0.333 HKD. This represents an increase of 0.89 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 57.36 percent compared to the value the year prior.
The 1 year change in percent is 57.36.
The 3 year change in percent is 1.69.

The Serie's long term average value is 0.352 Hong Kong Dollars. It's latest available value, on 06/30/2025, is 5.42 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2023, to it's latest available value, on 06/30/2025, is +64.45%.
The Serie's change in percent from it's maximum value, on 12/31/2021, to it's latest available value, on 06/30/2025, is -55.22%.

Ebitda Per Share for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebitda Per Share905,699,262,464.00
LogoJohnson & Johnson - Ebitda Per Share486,508,953,600.00
LogoAbbVie Inc - Ebitda Per Share399,570,305,024.00
LogoRoche Holding AG - Ebitda Per Share317,433,206,677.55
LogoAstraZeneca PLC - Ebitda Per Share280,205,508,085.11